Z

Zhejiang Taimei Medical Technology Co Ltd
F:A2V

Watchlist Manager
Zhejiang Taimei Medical Technology Co Ltd
F:A2V
Watchlist
Price: 0.585 EUR Market Closed
Market Cap: €329.7m

Wall St Price Targets

A2V Price Targets Summary
Zhejiang Taimei Medical Technology Co Ltd

There are no price targets for A2V.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Zhejiang Taimei Medical Technology Co Ltd Competitors:
Price Targets
OKTA
Okta Inc
1% Upside
FUTR
Future PLC
37% Upside
NIVABUPA
Niva Bupa Health Insurance Company Ltd
21% Upside
FER
Ferrovial SE
18% Upside

Revenue
Forecast

-2% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-2% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 12%.

Gross Profit
Forecast

5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Zhejiang Taimei Medical Technology Co Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Zhejiang Taimei Medical Technology Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Zhejiang Taimei Medical Technology Co Ltd
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is A2V's stock price target?
Not Available

A2V does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Zhejiang Taimei Medical Technology Co Ltd?
Projected CAGR
12%

Over the last 3 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett